Document:

Exhibit 10.43

 

LESLIE J. GOLDMAN : EMPLOYMENT AGREEMENT

 

	Title/Position	 	Sr. Vice President For Business Development
	 	 	 
	Term of Agreement	 	2 years
	 	 	 
	Cash Comp (Salary)	 	$264,000
	 	 	 
	Cash Comp (Bonuses)	 	N/A
	 	 	 
	Total New Equity	 	Options for 2,250,000 shares of common stock-
	 	 	·    1/3 to vest upon signing,
	 	 	·    1/3 to vest monthly over the 2 year term (31,250 options per month), and
	 	 	·    1/3 to vest (or issue) pursuant to the following milestones:
	 	 	 	 
	
        New Equity Linked To

        Milestones
	 	Milestones to be determined by the Board.

 

 

    	 

    	 

    

 

	Termination	 	Your employment will be "at will" during the 2-year:term  of the Agreement.  You may resign at any time during the term either with the amount of advance notice required below, or without such amount of advance notice (in which case certain consequences apply as described below).   NWBT may terminate you at any time during the term "For Cause" or "Without Cause."
	 	 	 
	Severance	 	3 months if you are terminated Without Cause, conditional upon reasonable cooperation and compliance with confidentiality, non-competition, best efforts and good faith throughout the severance period;  the severance ceases when you begin a new position if that occurs prior to 3 mos.
	 	 	 
	 	 	No severance if you resign or are terminated For Cause.
	 	 	 
	 	 	"Cause" includes, but is not limited to, malfeasance, material non-performance or materially inadequate performance following written notice or other communication from the Board of such cause and a reasonable period of time to cure it one time.
	 	 	 
	Effect of Termination On Options	 	If you are terminated "Without Cause," all of the options which are part of the total earnable under this
    Agreement and which have not yet issued/vested will accelerate and become     fully vested so long as you execute a
    separation and release agreement reasonably acceptable to the Company, and you do not     directly or indirectly work for or
    with a Competing Company (as defined below) in any capacity (employee, director, adviser, collaborator, etc.) for 6 months
    after termination.

 

 

    	2

    	 

    

 

	 	 	If you are terminated "For Cause," the vesting of your options will stop;  all of the options which are part of the total earnable under this Agreement and which have not yet qualified for issuance/vesting will become void and no longer available to be earned/vested.  All of the options which have already issued/vested will expire thirty (30) days after such termination.
	 	 	 
	 	 	If you resign, the vesting of your options will stop.  If your resignation complies with the notice, non-competition and best efforts and good faith requirements below, your options will be exercisable for sixty (60) days following the last day of employment.  If your resignation does not comply with the notice and best efforts and good faith requirements below, then your options will be partially forfeited as provided below, and the remainder will expire within thirty (3'0) days after such resignation.
	 	 	 
	Advance Notice of Resignation;  Partial Clawback Of Options	 	If you provide advance notice of at least 45 days, then you will not forfeit any issued/vested options.
	 	 	If you provide notice of more than 30 days but less than 45 days, then you will forfeit any options issued/vested in preceding 60 days.
	 	 	 
	 	 	If you provide notice of less than 30 days, then you will forfeit any options issued/vested in preceding 90 days.
	 	 	 
	Best Efforts;  Good Faith	 	During the advance notice period, you must devote best efforts, in good faith, to the Company's business and any personnel transition, clinical trial transition and other transitions.
	 	 	 
	Benefits	 	Healthcare insurance   [Company's existing coverage]
	 	 	 
	Vacation	 	4 weeks- no carryover: use it or lose it  [Company standard]
	 	 	 
	Tax and other reimbursement/ indemnification	 	Company will pay or reimburse any tax and/or other costs associated with or resulting from this Employment Agreement, including without limitation the exercise price of the options.
	 	 	 
	
        Effect of Operational

        Change in Control
	 	If a "true" (operational) change in control occurs (not a technical change in
    control due to inves1ment in financing(s)) then all of the options which are part of the total earnable under this Agreement and which have not yet issued/vested will accelerate and become fully vested.

 

    	3

    	 

    

 

	Confidentiality	 	Execute or re-execute/extend Company's standard CDA.
	 	 	 
	Assignment of Inventions	 	All inventions conceived or developed during term of Company employment by the Company must be assigned to the Company.  (No "nights or weekends" exceptions.)  Must execute assignment agreement and limited power of attorney enabling the Company to make filings and take actions necessary to implement such assignments of inventions.
	 	 	 
	Outside Activities	 	Outside professional activities are to be conducted in a manner compatible with the professional obligations pursuant to this Employment Agreement.
	 	 	 
	Indemnification	 	To fullest extent allowed by law for any losses, damages, expenses, claims, etc. arising out of or relating performance of job (within scope of position, with proper internal approvals, etc.), including reasonable attorneys' fees.

 

 

[signatures of the following page]

 

    	4

    	 

    

 

The parties hereby agree that execution of this Term Sheet Agreement
constitutes a binding agreement of the parties. The parties also hereby agree to use best efforts, in good faith, as promptly as
reasonably practicable after execution of this Term Sheet Agreement, to agree upon and execute definitive agreement documents expressing
more fully the same terms and conditions already expressed and agreed in this Term Sheet Agreement.

 

Agreed and Accepted:

 

	NORTHWEST BIOTHERAPEUTICS	 	MR. LESLIE J. GOLDMAN
	 	 	 
	By:	/s/Alton Boynton	 	/s/ Leslie J. Goldman
	 	 	 
	Name: Alton Boynton	 	 
	 	 	 
	Title: CEO	 	 
	 	 	 
	Date: 	May 31, 2011	 	Date: 	May 31, 2011

 

    	5Exhibit 10.44

 

LINDA F. POWERS : EMPLOYMENT AGREEMENT

 

	Title/Position	 	CEO
	 	 	 
	Term of Agreement	 	2 years
	 	 	 
	Cash Comp (Salary)	 	$360,000
	 	 	 
	Cash Comp (Bonuses)	 	NA
	 	 	 
	Total New Equity  Upon Signing	 	Options equivalent to 9% of equity (14,220,000 options), with an exercise price of 57 cents per share –
	 	 	·	1/3 to vest upon signing,
	 	 	·	1/3 to vest monthly over the 2 year term of this Agreement (197,500 per month), and
	 	 	·	1/3 to vest pursuant to the performance milestones below
	 	 	 
	New Equity Linked To Milestones	 	Milestones to be determined by the Board
	 	 	 
	Termination	 	Your employment will be “at will” during the 2-year term of the Agreement.  You may resign at any time during the term either with the amount of advance notice required below, or without such amount of advance notice (in which case certain consequences apply as described below).   NWBT may terminate you at any time during the term “For Cause” or “Without Cause.” 
	 	 	 
	Severance	 	3 months if you are terminated Without Cause, conditional upon reasonable cooperation and compliance with confidentiality, non-competition, best efforts and good faith throughout the severance period; the severance ceases when you begin a new position if that occurs prior to 3 mos
	 	 	 
	 	 	No severance if you resign or are terminated For Cause. 
	 	 	 
	 	 	“Cause” includes, but is not limited to, malfeasance, material non-performance or materially inadequate performance following written notice or other communication from the Board of such cause and a reasonable period of time to cure it one time. 
	 	 	 
	Effect of Termination On Options	 	If you are terminated “Without Cause,” all of the options which are part of the total earnable under this Agreement and which have not yet issued/vested will accelerate and become fully vested so long as you execute a separation and release agreement reasonably acceptable to the Company, and you do not directly or indirectly work for or with a Competing Company (as defined below) in any capacity (employee, director, adviser, collaborator, etc.) for 6 months after termination. 

 

    	 

    	 

    

 

	 	 	If you are terminated “For Cause,” the vesting of your options will stop;  all of the options which are part of the total earnable under this Agreement and which have not yet qualified for issuance/vesting will become void and no longer available to be earned/vested.  All of the options which have already issued/vested will expire thirty (30) days after such termination. 
	 	 	 
	 	 	If you resign during the term of this Agreement, the vesting of your options will stop.  If your resignation complies with the notice, non-competition and best efforts and good faith requirements below, your options will be exercisable for sixty (60) days following the last day of employment.  If your resignation does not comply with the notice and best efforts and good faith requirements below, then your options will be partially forfeited as provided below, and the remainder will expire within thirty (30) days after such resignation.
	 	 	 
	Advance Notice of Resignation; Partial Clawback of Options	 	If you provide advance notice of at least 45 days, then you will not forfeit any issued/vested options.
	 	 	 
		 	If you provide notice of more than 30 days but less than 45 days, then you will forfeit any options issued/vested in preceding 60 days.
	 	 	 
	 	 	If you provide notice of less than 30 days, then you will forfeit any options issued/vested in preceding 90 days.
	 	 	 
	Best Efforts;  Good Faith	 	During the advance notice period, you must devote best efforts, in good faith, to the Company’s business and any personnel transition, clinical trial transition and other transitions.
	 	 	 
	Benefits	 	Healthcare insurance  [Company’s existing coverage]
	 	 	 
	Vacation	 	4 weeks – no carryover: use it or lose it  [Company standard]
	 	 	 
	Tax and other reimbursement/ indemnification	 	Company will pay or reimburse any tax and/or other costs associated with or resulting from this Employment Agreement, including without limitation the exercise price of the options.

 

    	2

    	 

    

 

	Effect of Operation Change in Control	 	If a “true” (operational) change in control occurs (not a technical change in control due to investment in financing(s), then all of the options which are part of the total earnable under this Agreement and which have not yet issued/vested will accelerate and become fully vested.
	 	 	 
	Confidentiality	 	Execute or re-execute/extend Company’s standard CDA.
	 	 	 
	Assignment of Inventions	 	All inventions conceived or developed during term of Company employment by the Company must be assigned to the Company.  (No “nights or weekends” exceptions.)  Must execute assignment agreement and limited power of attorney enabling the Company to make filings and take actions necessary to implement such assignments of inventions.
	 	 	 
	Outside Activities	 	Outside professional activities are to be conducted in a manner compatible with professional obligations pursuant to this Employment Agreement.
	 	 	 
	Indemnification	 	To fullest extent allowed by law for any losses, damages, expenses, claims, etc. arising out of or relating performance of job (within scope of position, with proper internal approvals, etc.), including reasonable attorneys’ fees.

 

The parties hereby agree that execution of this Term Sheet Agreement
constitutes a binding agreement of the parties. The parties also hereby agree to use best efforts, in good faith, as promptly as
reasonably practicable after execution of this Term Sheet Agreement, to agree upon and execute the definitive agreement documents
expressing more fully the same terms and conditions already expressed and agreed in this Term Sheet Agreement.

 

(signatures on following page)

 

    	3

    	 

    

 

Agreed and Accepted: 

 

	NORTHWEST BIOTHERAPEUTICS	 	MS. LINDA F. POWERS
	 	 	 
	By: 	/s/ Alton Boynton	 	/s/ Linda F. Powers
	 	 	 	 
	Name: Alton Boynton	 	 
	 	 	 
	Title: CEO	 	 
	 	 	 
	Date: 	May 31, 2011	 	Date: 	May 31, 2011

 

    	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}]]